• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    LiveRamp and Walgreens Advertising Group Deliver Business Growth for Advertisers Through Robust Data Collaboration Partnership

    6/11/25 5:30:00 AM ET
    $RAMP
    $WBA
    EDP Services
    Technology
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $RAMP alert in real time by email

    WAG advertisers can now accelerate audience creation, activation, and measurement with flexibility and speed

    LiveRamp (NYSE:RAMP), the leading data collaboration partner, today announced it is powering Walgreens Advertising Group's (WAG) clean room solution. The partnership enables WAG, the retail media division of Walgreens, to increase access to its first-party data at speed, scale audience insights, and offer more transparency and control to advertisers. This enables brands to enhance media measurement across all platforms in the digital ecosystem and improve ROI with faster time-to-value.

    LiveRamp's data collaboration network enables WAG to unlock new insights, accelerate performance, and drive business growth. By strengthening WAG's identity infrastructure and ecosystem connectivity, LiveRamp extends the efficiency of WAG's first-party data solutions to improve personalization capabilities, access data at scale, and deliver real-time campaign performance insights. Using the LiveRamp Clean Room, granular campaign measurement is also possible across offsite publishers and walled gardens. These enhancements bring a multitude of new benefits to WAG advertisers and partners, including:

    • Expanded collaboration based on Walgreens' unique national customer base, including more than 101 million myWalgreens loyalty members who generate billions of signals daily from online, in-store, and delivery activities
    • Self-service access to syndicated and custom audience creation for more personalized targeting across the customer journey, using Walgreens' rich data combined with brands' desired media channels
    • Activation at greater speed and scale across programmatic, walled garden, CTV, social, search, and buy- and sell-side platforms
    • Consolidated measurement to optimize the performance of managed and self-service campaigns with more accurate and granular insights
    • Enhanced interoperability, flexibility, and data governance to minimize the movement of data while collaborating with partners

    "We're committed to empowering our partners with a transparent, self-service approach that allows them to leverage data on their own terms—with privacy in mind," said Abishake Subramanian, Group Vice President of Customer Marketing and Media Monetization at Walgreens. "Our focus is on investing in leading technologies that enhance data portability, audience scalability, and campaign measurability—while executing responsibly to create more meaningful experiences for Walgreens shoppers. With some of the most integrated and interoperable solutions in the marketplace that support upholding strict privacy protections, partners like LiveRamp play a key role in helping WAG deliver on this vision."

    "LiveRamp and WAG are helping advertisers get more from their media network investment by improving access, activation, and measurement across any partner or platform with speed and scale," said Vihan Sharma, Chief Revenue Officer at LiveRamp. "WAG is already a highly differentiated offering in retail and healthcare that decouples data and media. Advertisers can now further deepen their customer understanding, improve cross-channel performance, and enhance closed-loop measurement to drive ROI."

    To learn more about the Walgreens Advertising Group, including the new offerings, visit walgreensadvertisinggroup.com.

    Uncover the brand-building power of media networks at liveramp.com.

    About Walgreens

    Founded in 1901, Walgreens (www.walgreens.com) has a storied heritage of caring for communities for generations, and proudly serves nearly 9 million customers and patients each day across its approximately 8,500 stores throughout the U.S. and Puerto Rico, and leading omni-channel platforms. Walgreens has approximately 220,000 team members, including nearly 90,000 healthcare service providers, and is committed to being the first choice for retail pharmacy and health services, building trusted relationships that create healthier futures for customers, patients, team members and communities.

    Walgreens is the flagship U.S. brand of Walgreens Boots Alliance, Inc. (NASDAQ:WBA), an integrated healthcare, pharmacy and retail leader. Its retail locations are a critical point of access and convenience in thousands of communities, with Walgreens pharmacists playing a greater role as part of the healthcare system and patients' care teams than ever before. Walgreens Specialty Pharmacy provides critical care and pharmacy services to millions of patients with rare disease states and complex, chronic conditions.

    About LiveRamp

    LiveRamp is the leading data collaboration partner, empowering marketers and media owners to deliver exceptional experiences and drive measurable performance everywhere it matters with the world's most powerful data collaboration network.

    Built on a foundation of strict neutrality, unmatched interoperability, and global scale, LiveRamp enables organizations to maximize measurable outcomes and create lasting business value. Trusted by the world's leading brands, retailers, financial services providers, and healthcare innovators, LiveRamp is shaping the future of responsible data collaboration in an AI-driven, outcomes-focused world.

    LiveRamp is headquartered in San Francisco, California, with offices worldwide. Learn more at LiveRamp.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250611638516/en/

    Media Contacts

    Kamara Turner

    [email protected]

    Michelle Millsap

    [email protected]

    Get the next $RAMP alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $RAMP
    $WBA

    CompanyDatePrice TargetRatingAnalyst
    LiveRamp Holdings Inc.
    $RAMP
    7/9/2025$45.00Buy
    DA Davidson
    Walgreens Boots Alliance Inc.
    $WBA
    2/28/2025$11.00 → $9.00Hold → Sell
    Deutsche Bank
    LiveRamp Holdings Inc.
    $RAMP
    1/13/2025$35.00Overweight → Equal-Weight
    Morgan Stanley
    LiveRamp Holdings Inc.
    $RAMP
    10/29/2024$25.00Equal Weight
    Wells Fargo
    Walgreens Boots Alliance Inc.
    $WBA
    2/26/2024$23.00Market Perform
    Leerink Partners
    Walgreens Boots Alliance Inc.
    $WBA
    2/20/2024Hold → Reduce
    HSBC Securities
    LiveRamp Holdings Inc.
    $RAMP
    2/1/2024$50.00Outperform
    Evercore ISI
    Walgreens Boots Alliance Inc.
    $WBA
    1/3/2024$21.00Underweight
    Barclays
    More analyst ratings

    $RAMP
    $WBA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • LiveRamp to Discuss First Quarter FY26 Financial Results

      SAN FRANCISCO, July 23, 2025 (GLOBE NEWSWIRE) -- LiveRamp® (NYSE:RAMP), the leading global data collaboration platform, today announced that its fiscal 2026 first quarter financial results will be released on Wednesday, August 6, 2025 after the financial markets close. A conference call to discuss the results will be held on the same day at 1:30 p.m. PT. A live webcast of the conference call can be accessed on the LiveRamp Investor Relations website. Additionally, the conference call can be accessed via the telephone by dialing (800) 715-9871 or (646) 307-1963. The conference call ID is 5883383. To automatically receive LiveRamp financial news by email, please visit the company's Invest

      7/23/25 4:05:00 PM ET
      $RAMP
      EDP Services
      Technology
    • Blazing Star Merger Sub, Inc. announces Tender Offer and Consent Solicitation for any and all Walgreens Boots Alliance, Inc.'s 3.600% senior notes due 2025, 2.125% senior notes due 2026, 3.450% notes due 2026, 8.125% notes due 2029, 3.200% Notes due 2030, 4.500% senior notes due 2034, 4.800% senior notes due 2044, 4.650% notes due 2046 and 4.100% Notes due 2050, and any and all of Walgreen Co.'s 4.400% notes due 2042

      NEW YORK, July 22, 2025 /PRNewswire/ -- Blazing Star Merger Sub, Inc. (the "Offeror" announced today the commencement of cash tender offers (each, an "Offer" and, collectively, the "Tender Offer") for any and all of Walgreens Boots Alliance, Inc.'s (NASDAQ:WBA) ("WBA") outstanding (1) 3.600% senior notes due 2025 (the "2025 Notes"), (2) 2.125% senior notes due 2026 (the "2.125% 2026 Notes"), (3) 3.450% notes due 2026 (the "3.450% 2026 Notes"), (4) 8.125% notes due 2029 (the "2029 Notes"), (5) 3.200% notes due 2030 (the "2030 Notes"), (6) 4.500% senior notes due 2034 (the "2034 Notes"), (7) 4.800% senior notes due 2044 (the "2044 Notes"), (8) 4.650% notes due 2046 (the "2046 Notes") and (9) 4

      7/22/25 7:09:00 PM ET
      $WBA
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Walgreens Boots Alliance Shareholders Overwhelmingly Approve Transaction with Sycamore Partners

      Transaction expected to close in the third or fourth quarter of calendar year 2025 Walgreens Boots Alliance, Inc. (NASDAQ:WBA) (the "Company" or "WBA") today announced that at the Company's Special Meeting of Shareholders (the "Special Meeting"), WBA shareholders approved the previously announced acquisition of the Company by entities affiliated with Sycamore Partners Management, L.P. ("Sycamore"). According to the preliminary results, approximately 96% of votes cast at the Special Meeting by all shareholders were voted in favor of the merger agreement proposal. In addition, approximately 95% of the votes cast at the Special Meeting by unaffiliated shareholders were voted in favor of th

      7/11/25 9:59:00 AM ET
      $WBA
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $RAMP
    $WBA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • DA Davidson initiated coverage on LiveRamp with a new price target

      DA Davidson initiated coverage of LiveRamp with a rating of Buy and set a new price target of $45.00

      7/9/25 8:30:34 AM ET
      $RAMP
      EDP Services
      Technology
    • Walgreens Boots Alliance downgraded by Deutsche Bank with a new price target

      Deutsche Bank downgraded Walgreens Boots Alliance from Hold to Sell and set a new price target of $9.00 from $11.00 previously

      2/28/25 7:36:45 AM ET
      $WBA
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • LiveRamp downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded LiveRamp from Overweight to Equal-Weight and set a new price target of $35.00

      1/13/25 8:27:16 AM ET
      $RAMP
      EDP Services
      Technology

    $RAMP
    $WBA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Executive Chairman of Board Pessina Stefano sold $9,163,161 worth of shares (832,258 units at $11.01) and bought $9,163,161 worth of shares (832,258 units at $11.01), decreasing direct ownership by 56% to 657,308 units (SEC Form 4)

      4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)

      4/29/25 8:49:21 PM ET
      $WBA
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Bhandari Inderpal S bought $54,150 worth of shares (3,000 units at $18.05) (SEC Form 4)

      4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)

      4/15/24 5:45:26 PM ET
      $WBA
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Mahajan Manmohan bought $116,280 worth of shares (6,000 units at $19.38) (SEC Form 4)

      4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)

      4/2/24 6:40:23 PM ET
      $WBA
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $RAMP
    $WBA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • September 12, 2023 - FDA Issues Warning Letters to Firms Marketing Unapproved Eye Products

      For Immediate Release: September 12, 2023 The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. These warning letters are part of the agency’s ongoing effort to protect Americans from potentially harmful ophthalmic products. Eye products addressed in the eight warning letters are illegal

      9/12/23 10:44:21 AM ET
      $WBA
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $RAMP
    $WBA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Huffines Robert Luther

      4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)

      7/11/25 5:21:10 PM ET
      $WBA
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form 4 filed by Director Jarrett Valerie B

      4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)

      7/11/25 5:19:48 PM ET
      $WBA
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form 4 filed by Director Lederer John Anthony

      4 - Walgreens Boots Alliance, Inc. (0001618921) (Issuer)

      7/11/25 5:15:15 PM ET
      $WBA
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $RAMP
    $WBA
    SEC Filings

    See more
    • SEC Form 8-K filed by Walgreens Boots Alliance Inc.

      8-K - Walgreens Boots Alliance, Inc. (0001618921) (Filer)

      7/15/25 4:30:52 PM ET
      $WBA
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Amendment: SEC Form SC 13E3/A filed by Walgreens Boots Alliance Inc.

      SC 13E3/A - Walgreens Boots Alliance, Inc. (0001618921) (Subject)

      7/11/25 4:34:10 PM ET
      $WBA
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form 8-K filed by Walgreens Boots Alliance Inc.

      8-K - Walgreens Boots Alliance, Inc. (0001618921) (Filer)

      7/11/25 4:30:33 PM ET
      $WBA
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $RAMP
    $WBA
    Financials

    Live finance-specific insights

    See more
    • LiveRamp to Discuss First Quarter FY26 Financial Results

      SAN FRANCISCO, July 23, 2025 (GLOBE NEWSWIRE) -- LiveRamp® (NYSE:RAMP), the leading global data collaboration platform, today announced that its fiscal 2026 first quarter financial results will be released on Wednesday, August 6, 2025 after the financial markets close. A conference call to discuss the results will be held on the same day at 1:30 p.m. PT. A live webcast of the conference call can be accessed on the LiveRamp Investor Relations website. Additionally, the conference call can be accessed via the telephone by dialing (800) 715-9871 or (646) 307-1963. The conference call ID is 5883383. To automatically receive LiveRamp financial news by email, please visit the company's Invest

      7/23/25 4:05:00 PM ET
      $RAMP
      EDP Services
      Technology
    • Walgreens Boots Alliance Shareholders Overwhelmingly Approve Transaction with Sycamore Partners

      Transaction expected to close in the third or fourth quarter of calendar year 2025 Walgreens Boots Alliance, Inc. (NASDAQ:WBA) (the "Company" or "WBA") today announced that at the Company's Special Meeting of Shareholders (the "Special Meeting"), WBA shareholders approved the previously announced acquisition of the Company by entities affiliated with Sycamore Partners Management, L.P. ("Sycamore"). According to the preliminary results, approximately 96% of votes cast at the Special Meeting by all shareholders were voted in favor of the merger agreement proposal. In addition, approximately 95% of the votes cast at the Special Meeting by unaffiliated shareholders were voted in favor of th

      7/11/25 9:59:00 AM ET
      $WBA
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Walgreens Boots Alliance Reports Fiscal 2025 Third Quarter Results

      Third quarter financial results Third quarter loss per share1 was $0.20 compared to earnings per share of $0.40 in the year-ago quarter. The decline in earnings per share was primarily driven by prior year after-tax gains related to fair value adjustments on variable prepaid forward derivatives and a partial sale of the Company's equity method investment in Cencora, and higher tax expense in the current quarter. Adjusted earnings per share (EPS)2 was $0.38 compared to adjusted EPS2 of $0.63 in the year-ago quarter. The decline in adjusted EPS2 was primarily driven by a higher adjusted effective tax rate2, higher incentive accruals, lower U.S. retail sales and lower equity earnings in

      6/26/25 7:00:00 AM ET
      $WBA
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $RAMP
    $WBA
    Leadership Updates

    Live Leadership Updates

    See more
    • From Fierce Rivals to Partners: Omar Tawakol joins super{set}, a venture studio that builds AI-powered, category-defining companies

      SAN FRANCISCO, March 4, 2025 /PRNewswire/ -- super{set}, the pioneering venture studio that founds, funds, and builds data-driven AI startups, today announced that Omar Tawakol has joined the firm as a General Partner. A seasoned entrepreneur and industry leader, Tawakol brings decades of experience in AI, data platforms, and enterprise software, further advancing super{set}'s mission. Tawakol is a highly respected innovator and is currently the co-founder and CEO of Rembrand, an AI-powered in-scene media and virtual product placement company. Before Rembrand, Tawakol founded

      3/4/25 9:00:00 AM ET
      $RAMP
      EDP Services
      Technology
    • Walgreens Appoints Jason Stenta as SVP and Chief Commercial Officer

      Stenta will lead B2B commercial growth strategy as the company strengthens its role as the first choice for community pharmacy and health services in the U.S. Walgreens, an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, today announced the appointment of Jason Stenta as SVP and chief commercial officer. In this new role, Stenta will lead the company's commercial growth strategy, driving development and commercialization of B2B healthcare services built on the company's core assets, and enhancing partnerships with payers, health system providers and life sciences companies. This press release features multimedia. View the full release

      10/7/24 8:00:00 AM ET
      $WBA
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Walgreens Appoints Two New Leaders to its Retail and Customer Experience Team

      Names Tracey Koller as Chief Merchandising Officer and Sharmila Sudhakar as Group Vice President and Head of Digital Commerce Walgreens, the leading independent retail pharmacy and healthcare provider, today announced two key leadership appointments: Tracey Koller, senior vice president and chief merchandising officer, and Sharmila Sudhakar, group vice president and head of Walgreens digital commerce. The company believes these new appointments will significantly contribute to its efforts with regard to the turnaround of the business as the company focuses on enhancing the front of store and omnichannel experience for its customers while driving in-store efficiencies. This press release

      8/16/24 9:00:00 AM ET
      $WBA
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples

    $RAMP
    $WBA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Walgreens Boots Alliance Inc.

      SC 13G/A - Walgreens Boots Alliance, Inc. (0001618921) (Subject)

      10/18/24 12:45:41 PM ET
      $WBA
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • Amendment: SEC Form SC 13D/A filed by Walgreens Boots Alliance Inc.

      SC 13D/A - Walgreens Boots Alliance, Inc. (0001618921) (Filed by)

      8/20/24 4:05:58 PM ET
      $WBA
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
    • SEC Form SC 13G/A filed by Walgreens Boots Alliance Inc. (Amendment)

      SC 13G/A - Walgreens Boots Alliance, Inc. (0001618921) (Subject)

      2/13/24 5:17:30 PM ET
      $WBA
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples